Meet Our Team
Michael Burnam, MD
CEO and Founder
Award-winning scientist, inventor, and clinician with thirty years of biotech executive experience. Co-invented one of the first heart attack blood tests, was nominated for the Yallow-Berson International Prize in Immunology, and invented and achieved FDA clearance for a pre-calibrated and disposable potassium blood test.
Eli Gang, MD
Chief Medical Officer, Executive VP
and Co-Founder
Internationally known electrophysiologist and inventor, Clinical Professor at UCLA and Cedars Sinai Medical Center, and author of more than 150 papers on electrophysiology and cardiac pacing.
Michael Coyle, MBA
Board of Directors
Coyle served as Executive Vice President and President for the Cardiovascular Portfolio at Medtronic, a position he held until November 2020. He was responsible for optimizing Medtronic enterprise performance by supporting capital allocation, talent management, investments, and collaboration to create value across all of Medtronic’s Operating Units. Prior to Medtronic, he provided leadership consulting services to private equity, venture capital, and medical device technology firms. From 2001 to 2007, he served as a divisional president at St. Jude Medical where he led the company’s global pacemaker, implantable cardioverter defibrillator, and cardiac resynchronization businesses. Coyle also led the company’s Daig Catheter division in an earlier president role and held numerous leadership positions at Eli Lilly & Company.
Brent Shelton, MBA
Director of Business Development
Former Senior Business Program Manager for Medtronic involved with mergers & acquisitions, integration, business development and technology scouting, Former VP R&D Cardialen (implantable cardiac arrhythmia device).
Robert Develle, PA
Consultant
Involved with BaroPace’s Clinical Affairs. Directed clinical study operations for St Jude Medical/Abbott for several large human studies including most recently a pivotal randomized FDA trial of 236 enrolled subjects.
Srikanth Jadcherla, MS
Technology Advisor
Engineer, Educator and Entrepreneur and one of the world’s leading experts on mobile electronics’ design and verification. Chairman of Global Technology University and Founder/CEO of iMedrix Inc in addition to helping med-tech startups architect lasting solutions. Recipient of the Intel Achievement Award and has 10 patents.
Kenneth Ellenbogen, MD
Chairman of the Scientific Advisory Board
Director of Clinical Cardiac Electrophysiology and Pacing on the MCV Campus, Virginia Commonwealth University. He currently holds the Kimmerling Professor of Medicine. He has published more than 390 original scientific reports and over 200 book chapters, editorials and review articles. Dr. Ellenbogen is the editor or co-editor of five textbooks on cardiac electrophysiology and pacing.
Uri Elkayam, MD
Scientific Advisory Board
Professor of Medicine and a Professor of Obstetrics and Gynecology at the University of Southern California. Nationally and internationally known expert in heart failure and heart disease in pregnancy. Present or past editorial board member of several prestigious cardiovascular journals including the Journal of the American College of Cardiology, Heart Failure, Heart Failure Reviews, Journal of Preventive Cardiology, and Cardiology in Review.
Mark W. Kroll, PhD, FACC, FHRS, FIEEE, FAIMBE
Scientific Advisory Board
Biomedical scientist specializing in Bioelectricity and Biomechanics. Former Senior VP and Chief Technology Officer of St Jude Medical. Author of hundreds of peer-reviewed scientific papers and over 380 issued US patents, the vast majority for implantable medical devices. Adjunct full professor of Biomedical Engineering at California Polytechnic University.
Elisabeth Neely, BA, BS
Scientific Advisory Board
Former VP and Global Director of Regulatory Affairs for St Jude Medical, Senior VP for Clinical and Regulatory Affairs for Procyrion, Inc. Regulatory consultant to biomedical companies.
Sanjiv J. Shah, MD
Scientific Advisory Board
Director of Research, Bluhm Cardiovascular Institute, and Director, Center for Deep Phenotyping and Precision Therapeutics, Institute for Augmented Intelligence in Medicine, Northwestern University Feinberg School of Medicine. He currently holds the Stone Endowed Professor of Medicine. He has published more than 450 original scientific reports and over 150 book chapters, editorials, and review articles. Dr. Shah is an internationally recognized expert in heart failure with preserved ejection fraction (HFpEF), and he is currently the principal investigator of the Data Translation Center for the large-scale, multicenter NIH HeartShare Study. He has also served in leadership roles in numerous international heart failure clinical trials.
Domenic Sica, MD
Scientific Advisory Board.
Professor of Pharmacology, Virginia Commonwealth University, Richmond, Virginia. National and international author and speaker in hypertension. Served as Principal Investigator for multiple national clinical trials in hypertension.
Bradley Burnam
Board Advisor and Biotechnology Consultant
Founder and CEO of Turn Therapeutics. With a Masters from Stanford University, Mr. Burnam is a regulatory and formulation expert who has singlehandedly developed multiple FDA-cleared products serving chronic wound care and dermatology.
Michael Burnam, MD
CEO and Founder
Award-winning scientist, inventor, and clinician with thirty years of biotech executive experience. Co-invented Read More
Eli Gang, MD
Chief Medical Officer, Executive VP and Co-Founder
Internationally known electrophysiologist and inventor, Clinical Professor at UCLA and Cedars Sinai Medical Center, Read More
Michael Coyle, MBA
Board of Directors
Coyle served as Executive Vice President and President for the Cardiovascular Portfolio at Medtronic, a position he held until Read More
Brent Shelton, MBA
Director of Business Development
Former Senior Business Program Manager for Medtronic involved with mergers & acquisitions, integration, business Read More
Robert Develle, PA
Consultant
Involved with BaroPace’s Clinical Affairs. Directed clinical study operations for St Jude Medical/Abbott for several Read More
Srikanth Jadcherla, MS
Technology Advisor
Engineer, Educator and Entrepreneur and one of the world’s leading experts on mobile electronics’ design and Read More
Kenneth Ellenbogen, MD
Chairman of the Scientific Advisory Board
Director of Clinical Cardiac Electrophysiology and Pacing on the MCV Campus, Virginia Commonwealth University. Read More
Uri Elkayam, MD
Scientific Advisory Board
Professor of Medicine and a Professor of Obstetrics and Gynecology at the University of Southern California. Read More
Mark W. Kroll, PhD, FACC, FHRS, FIEEE, FAIMBE
Scientific Advisory Board
Biomedical scientist specializing in Bioelectricity and Biomechanics. Former Senior VP and Chief Technology Read More
Elisabeth Neely, BA, BS
Scientific Advisory Board
Former VP and Global Director of Regulatory Affairs for St Jude Medical, Senior VP for Clinical and Regulatory Affairs for Procyrion, Inc. Read More
Sanjiv J. Shah, MD
Scientific Advisory Board
Director of Research, Bluhm Cardiovascular Institute, and Director, Center for Deep Phenotyping and Precision Read More
Domenic Sica, MD
Scientific Advisory Board.
Professor of Pharmacology, Virginia Commonwealth University, Richmond, Virginia. National and international author Read More
Bradley Burnam
Board Advisor and Biotechnology Consultant
Founder and CEO of Turn Therapeutics. With a Masters from Stanford University, Mr. Burnam is a regulatory and Read More